IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5.


Autoria(s): Antaki N.; Bibert S.; Kebbewar K.; Asaad F.; Baroudi O.; Alideeb S.; Hadad M.; Abboud D.; Sabah H.; Bochud P.Y.; Negro F.
Data(s)

2012

Identificador

https://serval.unil.ch/?id=serval:BIB_86AEF326B376

isbn:1468-3288 (Electronic)

pmid:22345656

doi:10.1136/gutjnl-2012-302019

isiid:000309602800017

Idioma(s)

en

Fonte

Gut, vol. 61, no. 11, pp. 1640-1641

Palavras-Chave #Antiviral Agents/therapeutic use; Female; Hepacivirus/genetics; Hepatitis C, Chronic/drug therapy; Humans; Interleukins/genetics; Male; Polymorphism, Single Nucleotide
Tipo

info:eu-repo/semantics/article

article